ViaDerma, Inc. Stock

VDRM

US92555K1016

Biotechnology & Medical Research

Market Closed - OTC Markets 13:45:59 2026-06-03 EDT			5-day change	1st Jan Change
0.000300 ^USD	-25.00%		+200.00%	+50.00%

25-01-21	ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India	CI
24-08-13	ViaDerma, Inc. Announces Commencement of the Registration Process in Kenya, Namibia, and Tanzania for Strategic Expansion into East and Southern Africa	CI

ViaDerma, Inc. is a pharmaceutical company. The Company is engaged in the manufacture and sale of pharmaceutical related products in the United States of America. The Companyâ€™s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The Company also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. Its products are based on a patent-pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company utilizes a specific trade secret formulation system in the manufacture of all products. The Companyâ€™s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Companyâ€™s subsidiary is ViaDerma, II Inc.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
26-09-28	US$0.000200	-.--%	25,000

Real-time OTC Markets

More quotes

Stock Market
Stocks
VDRM Stock

As early as today, start finding the best investment opportunities!

Market Cap	6.31M 5.55M 5.24M 4.76M 8.93M 605M 8.98M 62.79M 24.25M 309M 23.67M 23.16M 993M	P/E 2015	10.7x	P/E 2016	-3.3x
Enterprise Value	6.6M 5.81M 5.49M 4.98M 9.35M 634M 9.41M 65.75M 25.39M 323M 24.79M 24.25M 1.04B	EV / Sales 2015	1.5x	EV / Sales 2016	3.63x
Free-Float	99%	Yield 2015 *	-	Yield 2016	-

25-01-21	ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India	CI
24-08-13	ViaDerma, Inc. Announces Commencement of the Registration Process in Kenya, Namibia, and Tanzania for Strategic Expansion into East and Southern Africa	CI
24-08-13	ViaDerma, Inc. Announces Shipment of 500,000 Units of its Product to Nigeria	CI
24-08-01	ViaDerma, Inc. Finalizes Distribution Agreements in Dubai	CI
23-03-16	ViaDerma, Inc. Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product	CI
23-03-08	ViaDerma Announces Intent to Launch New Minoxidil Hair Regrowth Product	CI
22-09-15	ViaDerma, Inc. Successfully Completes Quality Control Testing of Its New Vitastem Products	CI
21-10-04	ViaDerma, Inc. Set to Launch Two New and Improved Versions of Its Flagship Product, Vitastem and Vitastem Ultra	CI
21-06-24	ViaDerma, Inc. Provides Updates on Current Business Activities	CI
21-06-02	ViaDerma, Inc. Announces Expansion of Its Current Licensing Agreement	CI
21-05-13	ViaDerma, Inc. Nearing Initial Order from Large Hospital Network	CI
21-04-08	ViaDerma, Inc. Provides Revenue Guidance for the First Quarter of 2021	CI
21-01-21	ViaDerma, Inc. Completes a Licensing Agreement with a Group of Affiliate Wound Care Medical Practices Operating in Six States	CI

25-07-16	ViaDerma Announces Posting of Annual Report and Ongoing Evaluation of Public Status in Response to Market Changes	AQ
25-06-04	ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance	AQ
25-01-21	ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India	AQ
24-12-10	ViaDerma Announces Significant 2024 Achievements and International Expansion	AQ
24-10-03	ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth	AQ

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0.01
3 years	0		0.02
5 years	0		0.03
10 years	0		0.08

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VIADERMA, INC.	-25.00%	+200.00%	+50.00%	-97.37%	247K
LONZA GROUP AG	+2.64%	+6.45%	+11.87%	+38.40%	49.06B
IQVIA HOLDINGS INC.	+0.22%	+0.40%	+50.91%	+37.06%	44.6B
REVOLUTION MEDICINES, INC.	-1.58%	+4.66%	+359.34%	+614.38%	43.24B
BEONE MEDICINES AG	+1.70%	+0.36%	+12.56%	+99.27%	41.73B
CELLTRION, INC.	+0.51%	-1.71%	+5.18%	+46.87%	29.93B
MEDPACE HOLDINGS, INC.	-0.48%	-1.32%	+23.98%	+150.01%	17.19B
TEMPUS AI, INC.	+0.08%	+9.03%	+8.41%	-	15.35B
EUROFINS SCIENTIFIC SE	+1.76%	+0.85%	+29.13%	+48.42%	15.54B
ASCENDIS PHARMA A/S	+1.97%	-3.17%	-	-	15.11B
Average	-1.82%	+1.66%	+61.26%	+117.13%	27.18B
Weighted average by Cap.	+0.76%	+2.26%	+78.18%	+161.54%

ViaDerma, Inc. Stock

Stocks

VDRM

US92555K1016

Biotechnology & Medical Research

Valuation: ViaDerma, Inc.

Chart: ViaDerma, Inc.

Latest news: ViaDerma, Inc.

Press Releases: ViaDerma, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: ViaDerma, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

1 day	-25.00%
1 week	+200.00%
Current month	+200.00%
1 month	+200.00%
3 months	-25.00%
6 months	-25.00%
Current year	+50.00%

	2015	2016
Net sales	192K 169K 159K 145K 272K 18.41M 273K 1.91M 738K 9.39M 720K 704K 30.19M	252K 222K 210K 190K 357K 24.19M 359K 2.51M 969K 12.34M 946K 926K 39.66M
Net income	27.12K 23.85K 22.56K 20.46K 38.42K 2.6M 38.64K 270K 104K 1.33M 102K 99.62K 4.27M	-122K -107K -101K -91.88K -173K -11.69M -174K -1.21M -468K -5.97M -457K -447K -19.17M
Net Debt	288K 254K 240K 217K 408K 27.67M 411K 2.87M 1.11M 14.12M 1.08M 1.06M 45.37M	297K 261K 247K 224K 420K 28.49M 423K 2.96M 1.14M 14.54M 1.11M 1.09M 46.72M